Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma
S Faivre, T Le Chevalier, C Monnerat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2009
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
S Luminari, A Montanini, D Caballero, et al.
Seminars in Oncology
|
February 1, 1996
Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety
G Catimel, M Spielmann, V Dieras, et al.
Seminars in Oncology
|
February 1, 1997
Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience
G Catimel, M Spielmann, V Dieras, et al.
Oncology
|
June 16, 2001
Single-agent gemcitabine is active in previously treated metastatic breast cancer
M Spielmann, A Llombart-Cussac, S Kalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines
M Martin, M Spielmann, M Namer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients
J Baselga, A Llombart-Cussac, M Bellet, et al.
British Journal of Cancer
|
September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
X Pivot, E Raymond, B Laguerre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies
J P Delord, E Raymond, M Chaouche, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma
S Faivre, T Le Chevalier, C Monnerat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2009
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
S Luminari, A Montanini, D Caballero, et al.
Seminars in Oncology
|
February 1, 1996
Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety
G Catimel, M Spielmann, V Dieras, et al.
Seminars in Oncology
|
February 1, 1997
Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience
G Catimel, M Spielmann, V Dieras, et al.
Oncology
|
June 16, 2001
Single-agent gemcitabine is active in previously treated metastatic breast cancer
M Spielmann, A Llombart-Cussac, S Kalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines
M Martin, M Spielmann, M Namer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients
J Baselga, A Llombart-Cussac, M Bellet, et al.
British Journal of Cancer
|
September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
X Pivot, E Raymond, B Laguerre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies
J P Delord, E Raymond, M Chaouche, et al.
Page
of 2